Clinical Trial Update: Combination of MK3475 and Metronomic Cyclophosphamide in Patients With Advanced Sarcomas : Multicentre Phase II Trial [Phase 2]

View source ↗

Summary

Phase II multicenter trial evaluating pembrolizumab (MK3475) in combination with metronomic cyclophosphamide for advanced sarcoma; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sarcoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• MK3475 (pembrolizumab)

Snippet

Sponsor: Institut Bergonié | Conditions: Sarcoma | Phase 2 | Status: COMPLETED | Results posted: 2025-12-10